Related Experiment Video
Updated: May 23, 2026
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Efficient RNA interference in patients' acute lymphoblastic leukemia cells amplified as xenografts in mice
Ines Höfig1, Harald Ehrhardt, Irmela Jeremias
1Department of Gene Vectors, Helmholtz Center Munich - German Research Center for Environmental Health, Marchioninistr, 25, 81377 Munich, Germany. irmela.jeremias@helmholtz-muenchen.de.
Background:
Signaling studies in cell lines are hampered by non-physiological alterations obtained in vitro. Physiologic primary tumor cells from patients with leukemia require passaging through immune-compromised mice for amplification. The aim was to enable molecular work in patients' ALL cells by establishing siRNA transfection into cells amplified in mice.
Results:
We established delivering siRNA into these cells without affecting cell viability. Knockdown of single or multiple genes reduced constitutive or induced protein expression accompanied by marked signaling alterations.
Conclusion:
Our novel technique allows using patient-derived tumor cells instead of cell lines for signaling studies in leukemia.
Insights
Researchers developed a new method for studying leukemia by successfully transfecting patient-derived cells with siRNA. This technique enables molecular signaling studies using primary leukemia cells, overcoming limitations of traditional cell lines.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Cell line studies in leukemia are limited by in vitro alterations.
- Primary leukemia cells require mouse amplification for sufficient material.
- Existing methods hinder molecular analysis of patient-derived leukemia cells.
Purpose of the Study:
- To establish siRNA transfection in patient-derived leukemia cells amplified in mice.
- To enable molecular signaling studies using primary leukemia cells.
Main Methods:
- Developed and optimized siRNA delivery into mouse-amplified primary leukemia cells.
- Assessed cell viability post-transfection.
- Performed gene knockdown and analyzed downstream signaling alterations.
Main Results:
- Successfully delivered siRNA into primary leukemia cells without impacting viability.
- Gene knockdown effectively reduced protein expression.
- Observed significant alterations in cellular signaling pathways post-knockdown.
Conclusions:
- A novel technique for siRNA transfection in patient-derived leukemia cells was established.
- This method facilitates signaling studies using primary cells, offering a more physiologically relevant alternative to cell lines.
- The approach enhances the study of leukemia molecular mechanisms.
